Prima BioMed Ltd (PBMD) Gains as Analyst Sees Over 400% Upside
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
After-Hours Stock Movers 12/30: (PBMD) (CMRX) Higher; (AEZS) Lower (more...)
December 30, 2015 5:56 PM ESTPrima Biomed (NASDAQ: PBMD) 6.3% HIGHER; Roth Capital initiates coverage with a Buy rating and a price target of $6.00.
Chimerix (NASDAQ: CMRX) 4.4% HIGHER; In a 13G filing Steven... More
Roth Capital Starts Prima Biomed (PBMD) at Buy; $6 PT
December 30, 2015 4:37 PM ESTRoth Capital initiates coverage on Prima Biomed (NASDAQ: PBMD) with a Buy rating and a price target of $6.00.
Analyst Joseph Pantginis commented, "We are initiating coverage of Prima with a Buy rating and $6 price target. We believe Prima is in a leading position... More



